The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Oct. 15, 2014
Applicants:

The Regents of the University of California, Oakland, CA (US);

The Scripps Research Institute, La Jolla, CA (US);

Inventors:

Palmer Taylor, La Jolla, CA (US);

Zoran Radic, La Jolla, CA (US);

Valery Fokin, Lo Jolla, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/4164 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); A61K 38/46 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4164 (2013.01); A61K 31/4439 (2013.01); A61K 31/5377 (2013.01); A61K 38/465 (2013.01); A61K 45/06 (2013.01); C12Y 301/01008 (2013.01);
Abstract

Provided are N-alkyl imidazole 2-aldoximes, including cationic imidazolium and uncharged tertiary imidazole aldoximes, and compositions and methods for making and using them, including methods for reactivating human butyrylcholinesterase (hBChE) or acetylcholinesterase (hAChE) inhibited by organophosphate (OP). By administration of a composition of the invention, the inactive or conjugated hBChE-OP or hAChE-OP is reactivated and the catalytic cycle of turnover and inactivation of the OP is completed; and in alternative embodiments, secondary mechanisms of reversible protection of hBChE and hAChE from irreversible inactivation by OPs and reactivation of tissue AChE also contribute to overall efficacy.


Find Patent Forward Citations

Loading…